MedTrace Logo

Study of Buprenorphine Maintenance Treatment for Opioid Dependence in Primary Care

NCT00471042 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2019-04-23

No results posted yet for this study

Summary

The purpose of this treatment research study is to assess the effectiveness of buprenorphine maintenance treatment for opioid dependence delivered in a primary care clinic setting. This study will determine whether buprenorphine treatment in primary care is effective in reducing cravings, reducing illicit opioid use, reducing addiction severity, and retaining patients in primary care treatment for opioid dependence.

Conditions

  • Heroin Dependence
  • Opioid-Related Disorders
  • Substance Abuse, Intravenous

Interventions

DRUG

Buprenorphine

Dose is determined according to the participants' individual need.

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • New York State Psychiatric Institute

    lead OTHER

Principal Investigators

  • Erik W. Gunderson, M.D. · Columbia University

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-06-30
Primary Completion
2008-08-31
Completion
2012-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00471042 on ClinicalTrials.gov